{ "company_number": "08659153", "name": "Pharmalink Consultancy Limited", "url": "/company/08659153", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2013-08-21", "dissolved_on": null, "sic_codes": [ { "code": "70229", "description": "Management consultancy activities other than financial management", "section": "M", "section_name": "Professional, scientific and technical activities", "url": "/sic/70229" } ], "registered_address": { "id": 8770, "url": "/address/8770", "line1": "106 SOUTHVILLE CLOSE", "line2": "", "post_town": "FELTHAM", "county": "", "country": "ENGLAND", "postcode": "TW14 8AN" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08659153", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-11-30", "last_made_up": "2026-02-28", "category": "DORMANT", "filings": [ { "url": "/company/08659153/accounts/2026-02-28", "made_up_date": "2026-02-28", "period_start": "2026-02-28", "period_end": "2026-02-28", "entity_name": "Pharmalink Consultancy Limited", "dormant": true, "average_employees": "0.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "303.00", "creditors_due_within_one_year": "1305.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-1002.00", "total_assets_less_current_liabilities": "-1002.00", "net_assets_liabilities": "-1002.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-1002.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2026.zip" }, { "url": "/company/08659153/accounts/2025-02-28", "made_up_date": "2025-02-28", "period_start": "2025-02-28", "period_end": "2025-02-28", "entity_name": "Pharmalink Consultancy Limited", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "303.00", "creditors_due_within_one_year": "0.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "303.00", "total_assets_less_current_liabilities": "303.00", "net_assets_liabilities": "-1002.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-1002.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2025.zip" }, { "url": "/company/08659153/accounts/2024-02-28", "made_up_date": "2024-02-28", "period_start": "2024-02-28", "period_end": "2024-02-28", "entity_name": "Pharmalink Consultancy Limited", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "999.00", "creditors_due_within_one_year": "300.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "699.00", "total_assets_less_current_liabilities": "699.00", "net_assets_liabilities": "-300.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-300.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2024.zip" }, { "url": "/company/08659153/accounts/2023-02-28", "made_up_date": "2023-02-28", "period_start": "2023-02-28", "period_end": "2023-02-28", "entity_name": "Pharmalink Consultancy Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "5077.00", "creditors_due_within_one_year": "3921.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1156.00", "total_assets_less_current_liabilities": "1156.00", "net_assets_liabilities": "1156.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1156.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2023.zip" }, { "url": "/company/08659153/accounts/2021-08-31", "made_up_date": "2021-08-31", "period_start": "2021-08-31", "period_end": "2021-08-31", "entity_name": "Pharmalink Consultancy Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "5368.00", "creditors_due_within_one_year": "4343.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1025.00", "total_assets_less_current_liabilities": "1025.00", "net_assets_liabilities": "1025.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1025.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2021.zip" }, { "url": "/company/08659153/accounts/2020-08-31", "made_up_date": "2020-08-31", "period_start": "2020-08-31", "period_end": "2020-08-31", "entity_name": "Pharmalink Consultancy Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "11728.00", "creditors_due_within_one_year": "11218.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "510.00", "total_assets_less_current_liabilities": "510.00", "net_assets_liabilities": "510.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "510.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2021.zip" }, { "url": "/company/08659153/accounts/2019-08-31", "made_up_date": "2019-08-31", "period_start": "2019-08-31", "period_end": "2019-08-31", "entity_name": "Pharmalink Consultancy Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "30937.00", "creditors_due_within_one_year": "18250.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "12687.00", "total_assets_less_current_liabilities": "12687.00", "net_assets_liabilities": "12687.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "12687.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2020.zip" }, { "url": "/company/08659153/accounts/2018-08-31", "made_up_date": "2018-08-31", "period_start": "2018-08-31", "period_end": "2018-08-31", "entity_name": "Pharmalink Consultancy Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "9926.00", "creditors_due_within_one_year": "6408.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3518.00", "total_assets_less_current_liabilities": "3518.00", "net_assets_liabilities": "3518.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "3518.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2018.zip" }, { "url": "/company/08659153/accounts/2017-08-31", "made_up_date": "2017-08-31", "period_start": "2017-08-31", "period_end": "2017-08-31", "entity_name": "Pharmalink Consultancy Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "12185.00", "creditors_due_within_one_year": "7400.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "4785.00", "total_assets_less_current_liabilities": "4785.00", "net_assets_liabilities": "4785.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "4785.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2017.zip" }, { "url": "/company/08659153/accounts/2016-08-31", "made_up_date": "2016-08-31", "period_start": "2016-08-31", "period_end": "2016-08-31", "entity_name": "Pharmalink Consultancy Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "0.00", "debtors": null, "cash_bank_in_hand": "14836.00", "current_assets": "14836.00", "creditors_due_within_one_year": "11759.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3077.00", "total_assets_less_current_liabilities": "3077.00", "net_assets_liabilities": "3077.00", "called_up_share_capital": "2.00", "profit_loss_account_reserve": "3075.00", "shareholder_funds": "3077.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2017.zip" }, { "url": "/company/08659153/accounts/2015-08-31", "made_up_date": "2015-08-31", "period_start": "2015-08-31", "period_end": "2015-08-31", "entity_name": "Pharmalink Consultancy Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "13466.00", "current_assets": "13466.00", "creditors_due_within_one_year": "10785.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "2681.00", "total_assets_less_current_liabilities": "2681.00", "net_assets_liabilities": "2681.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "2680.00", "shareholder_funds": "2681.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2015.zip" }, { "url": "/company/08659153/accounts/2014-08-31", "made_up_date": "2014-08-31", "period_start": "2014-08-31", "period_end": "2014-08-31", "entity_name": "Pharmalink Consultancy Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "0.00", "debtors": "0.00", "cash_bank_in_hand": "14447.00", "current_assets": "14447.00", "creditors_due_within_one_year": "13350.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1097.00", "total_assets_less_current_liabilities": "1097.00", "net_assets_liabilities": "1097.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "1096.00", "shareholder_funds": "1097.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2015.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08659153/filing-history" }, "confirmation_statement": { "next_due": "2026-08-29", "last_made_up": "2025-08-15" }, "officers": [], "psc": [ { "name": "Mr Adinath Kale", "kind": "individual-person-with-significant-control", "person_url": "/person/87395", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "Indian", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Adinath Kale", "kind": "individual-person-with-significant-control", "person_url": "/person/87395", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "Indian", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-02T05:12:20.351914+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }